![David Hollander](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Hollander
Director/Board Member at
KIORA PHARMACEUTICALS, INC.
Net worth: - $ as of 2026-06-29
Profile
David A. Hollander is an Independent Director at Kiora Pharmaceuticals, Inc. since 2021 and a Director at Arnold & Mabel Beckman Foundation.
Former roles include VP & Head-Eye Care for Global Medical Affairs at Allergan, Inc., Chief Research & Development Officer at Aerie Pharmaceuticals, Inc. from 2019 to 2022, Chief Medical Officer & Senior Vice President at Ora, Inc., and Chief Medical Officer at Revance Therapeutics, Inc. from 2022 to 2025.
Education includes undergraduate studies at Stanford University, an MBA from The Wharton School of the University of Pennsylvania, and a doctorate from the University of Pennsylvania Medical Center.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-09 | 0 ( -.--% ) | - $ | 2026-06-29 |
David Hollander active positions
| Companies | Position | Start |
|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Director/Board Member | 2021-12-12 |
Arnold & Mabel Beckman Foundation
 Arnold & Mabel Beckman Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Director/Board Member | - |
Former positions of David Hollander
| Companies | Position | End |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2025-02-03 |
| AERIE PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2022-02-27 |
| ALLERGAN, INC. | Chief Tech/Sci/R&D Officer | - |
Ora, Inc.
 Ora, Inc. Medical SpecialtiesHealth Technology Develops ophthalmic products and provides clinical research services | Chief Tech/Sci/R&D Officer | - |
Training of David Hollander
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
53
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that discovers, develops and commercializes ophthalmic therapies for the treatment of patients with eye diseases | Health Technology |
Kiora Pharmaceuticals, Inc.
 Kiora Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for the treatment of ophthalmic diseases | Health Technology |
Revance Therapeutics, Inc.
 Revance Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for esthetics, skincare and therapeutics | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arnold & Mabel Beckman Foundation
Arnold & Mabel Beckman Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Ora, Inc.
Ora, Inc. Medical SpecialtiesHealth Technology Develops ophthalmic products and provides clinical research services | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania Medical Center
 University of Pennsylvania Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- David Hollander
